Covered recipient · General Payments record
KAMELIA KASHANI
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2021–2024
$699.20
- Reported across 29 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $261.36 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $94.92 | 4 |
| Amgen Inc. | $73.51 | 3 |
| ABBVIE INC. | $41.95 | 2 |
| Lilly USA, LLC | $28.17 | 2 |
| SANOFI-AVENTIS U.S. LLC | $22.81 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.43 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104035939 | CMS |
| ABBVIE INC. | $20.52 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104035941 | CMS |
| Amgen Inc. | $25.04 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117292976 | CMS |
| Amgen Inc. | $25.42 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117292978 | CMS |
| Amgen Inc. | $23.05 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117292980 | CMS |
| Lilly USA, LLC | $13.62 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135105273 | CMS |
| Lilly USA, LLC | $14.55 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135117777 | CMS |
| Novo Nordisk Inc | $20.27 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097524230 | CMS |
| Novo Nordisk Inc | $23.39 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097137011 | CMS |
| Novo Nordisk Inc | $16.52 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097233860 | CMS |
| Novo Nordisk Inc | $34.74 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096617932 | CMS |
| SANOFI-AVENTIS U.S. LLC | $22.81 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139839149 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.